26 - Anxiolytics & Hypnotics Flashcards

1
Q

Summarise GABA Neurotransmission

A

Precursor is glutamate

Glutamate is converted by glutamate decarboxylase (GAD) to form GABA

  • GAD needs vitamin B6 as its co-enzyme

GABA stored in vesicles in pre-synaptic terminals

Action potential arrives in short axon

Depolarisation

Influx of calcium

Exocytotic release of GABA into synaptic cleft

GABA diffuses across cleft

GABA stimulates post-synaptic receptors

  • these are chloirde ionophore receptors
  • GABAA receptors
  • these are type 1 receptors (ion-channel linked)
  • these sit on the post-synaptic neurones (often glutamatergic, but could be any other neurone)

GABA is regulating the activity of the post-synaptic neurone

Chloride ions flow into the post-synaptic neurone, hyperpolarisation (around -90mV)

Neurone is more difficult to excite

GABA is mainly removed by synapse by reuptake

  • into glial cells or into pre-synaptic neurone

Then is metabolised

  • by GABA transaminase

GABAB receptors are mainly pre-synaptic and are mainly regulatory

  • if too much GABA release, it acts on these receptors
  • this causes less GABA release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline GABA metabolism

A

GABA is firstly reuptaken

Then acted on by catabolic enzymes

Succinic acid is final product

  • then goes into TCA cycle in glial cells

GAD is a cytoplasmic enzyme

  • only in GABAergic neurones

GABA-T and SSDH are mitochondrial enzymes

Sodium Valproate and Vigabatrin are anti-convulsant drugs and then inhibit GABA metabolism. Raise central GABA levels.

Vigabatrin acts on GABA-T only (covalently)

Sodium Valproate acts on GABA-T and SSDH at therapeutic concentrations. Also, acts on VSSCs so can reduce glutamate release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the structure of the GABAA Receptor Complex

A

4 main proteins

  • GABA receptor protein
  • Barbiturate receptor protein
  • Chloride channel protein
  • Benzodiazepine receptor protein

When GABA binds:

  • binds to GABA receptor protein
  • causes linkage between GABA receptor protein and BDZ receptor protein
  • mediated by GABAmodulin peptide
  • this causes transient open of chloride channel
  • causes hyperpolarisation

When BDZs bind:

  • bind to BDZ receptor protein
  • enhance the opening of the channel
  • also, in the presence of a BDZ, there is a better binding of GABA to the receptor. this is reciprocated and causes better binding of BDZ

When Barbituates bind:

  • binds to barbituate receptor protein
  • enhances normal action of GABA
  • also in presence of a barbituate, there is better binding of GABA but this is not reciprocated
  • at higher doses, they can cause direct opening of chloride channel

Bicuculline:

  • competitive GABA receptor antagonist

Flumazenil:

  • competitive BDZ antagonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What effect do BDZs and BARBs have on the GABAA Receptor Complex?

A

Have no direct action on GABA

Need GABA to be present in order to work

Allosteric action - have their own binding sites of GABAA receptor

BARBs less selective than BDZs

  • BARBs may also reduce exictatory transmission, antagonist effects at glutamate receptors
  • BARBs can induce social anaesthesia
  • BARBs have relatively low margin of safety

BDZs = increase frequency of opening of chloride channel

BARBs = increase duration of chloride channel opening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical uses of …?

A

Anaesthetics - BARBs only

  • thiopentone
    • inducing agent
    • very highly lipid soluble

Anticonvulsants

  • diazepam
    • epilepsy
  • clonazepam
    • epilepsy
  • phenobarbital
    • less used because of side-effects

Anti-Spastics

  • diazepam
    • relaxation of tension

Anxiolytics

Sedatives/Hypnotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define ‘Anxiolytics’

A

ANXIOLYTICS

Remove anxiety without impairing mental or physical activity

‘Minor Tranquilisers’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define ‘Sedatives’

A

SEDATIVES
Reduce mental and physical activity without producing loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define ‘Hypnotics’

A

HYPNOTICS

Induce sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What characteristics should anxiolytics, sedatives and hypnotics ideally all have?

A

Ideally they should:

i) HAVE WIDE MARGIN OF SAFETY
ii) NOT DEPRESS RESPIRATION
iii) PRODUCE NATURAL SLEEP (HYPNOTICS)
iv) NOT INTERACT WITH OTHER DRUGS
v) NOT PRODUCE ‘HANGOVERS’
vi) NOT PRODUCE DEPENDENCE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the molecular structures of barbiturates

A

6 membered ring

Differ in R1, R2 and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical uses of barbiturates?

A

Range of clinical uses including

  • sedative/hypnotic
    • amobarbital
    • severe intractable insomnia
    • half life = 20-25 hours
    • intermediate acting BARB
    • superceded by BDZs, not gold-standard
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the unwanted effects of barbiturates?

A

UNWANTED EFFECTS OF BARBITURATES

NOT 1ST LINE DRUGS

Low Safety Margins

  • depress respiration
  • overdosing lethal

Alter Natural Sleep

  • low REM
  • lead to hangovers and irritability

Enzyme Inducers

Potentiate Effects of Other CNS Depressants

  • e.g. alcohol

Tolerance

Dependence

  • withdrawal syndrome
  • insomnia, anxiety, tremore, convulsions, death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the molecular structures of Benzodiazepines

A

Three-ring structure

Different substituent groups

  • relatively small changes between different BDZs leads to big changes in pharmacokinetics

Flumazenil

  • antagonist of BDZs
  • similar structure to BDZs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many Benzodiazepines are available and where do they act?

A

Around 20 available

All act at GABAA Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What determines the use of different Benzodiazepines?

A

All have similar potencies and profiles

Pharmacokinetics largely determine use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Outline the administration of Benzodiazepines

A

ADMINISTRATION

Well absorbed

Peak plasma concentration is at around 1 hour after administration

IV for status epilepticus as it is a medical emergency

17
Q

Outline the distribution of Benzodiazepines

A

DISTRIBUTION

Bind plasma proteins strongly

Highly lipid soluble and are therefore widly distributed

18
Q

Outline the metabolism of Benzodiazepines

A

METABOLISM

Usually extensive - especially in the liver

  • Short-Acting (Temazepam, Onazepam)
  • Long-Acting (Diazepam)
    • converted to active metabolites to make it long-acting
19
Q

Outline the excretion of Benzodiazepines

A

EXCRETION

URINE: Glucuronide conjugates

20
Q

Outline the duration of action of the Benzodiazepines

A

DURATION OF ACTION - VARY GREATLY

Short-Acting

Long-Acting

  • slow metabolism and/or active metabolites
21
Q

What are the advantages of Benzodiazepines?

A

Wide margin of safety (better than BARBs)

  • overdose = prolonged sleep (rousable)
  • flumazenil = antagonist
  • only mild effect on REM sleep
  • do not induce liver enzymes
22
Q

Give examples of anxiolytic Benzodiazepines

A

ANXIOLYTICS (‘long-acting’)

  • Diazepam (Valium)
  • Chlorodiazepoxide (Librium)
  • Nitrazepam

NOTE: Oxazepam

  • 8 hour half-life
  • hepatic impairment
  • shorter-acting
23
Q

Give examples of sedative/hynoptics Benzodiazepines

A

SEDATIVE/HYPNOTIC BENZODIAZEPINE - ‘short acting’

  • Temazepam
  • Oxazepam

NOTE:

  • Nitrazepam - 28 hour half-life - daytime anxiolytic effect
24
Q

Outline the unwanted effects of Benzodiazepines

A

UNWANTED EFFECTS

Sedation

Confusion

Amnesia

Ataxia (impaired manual skills)

Potentiate other CNS depressants (alcohols, barbiturates)

Tolerance

  • less than barbiturates
  • ‘tissue’ only

Dependence

  • withdrawal syndrome similar to barbiturates but less intense
  • withdraw slowly

Free Plasma Concentration is high

  • e.g. aspirin, heparin
25
Q

State another sedative/hynoptic not mentioned

A

ZOPICLONE

Short Acting

  • 5 hour half-life

Acts at Benzodiazepine Receptors

  • cyclopyrolone

Similar efficacy to benzodiazepines

Minimal hangover effects but dependency still a problem

26
Q

State some other anxiolytics not mentioned

A

ANXIOLYTICS

ANTI-DEPRESSANT

SSRIs

  • less sedation and dependence
  • delayed response
  • long-term treatment

ANTIEPILEPTIC

Valproate

Tiagabine

ANTIPSYCHOTIC

Olanzapine

Quetiapine

PROPANOLOL

Improves physical symptoms

  • tachycardia
  • tremor

BUSPIRONE

5HT1A Agonist

Fewer side-effects (less than sedation)

Slow onset of action (days/weeks)

27
Q

Benzodiazepines are used to treat ‘panic attacks’ and other anxiety states. By what mechanism do they produce their anti-anxiety effects?

A

Enhancement of the action of GABA at GABAA receptors

28
Q

Which of the following drugs is commonly used in the treatment of insomnia?

A: Thiopental

B: Phenytoin

C: Baclofen

D: Sodium valproate

E: Temazepam

A

Temazepam

29
Q

What type of neurones release GABA?

A

Short-axon interneurons

They have regulatory/inhibitory roles

GABA = most important inhibitory neurotransmitter in the brain

30
Q

What is the GABA shunt?

A

TCA cycle forms glutamate which is used to produce GABA

Succinic acid from the metabolism of GABA is then fed back into the TCA cycle

31
Q

Why are sedatives and hypnotics grouped together?

A

They same drugs are used as sedatives and hypnotics, just the dosage is changed